PhilArchive
open access
What Alzheimer’s Is Doing While We’re Looking at Plaques : On The Receiver, The Signal, And The Disease That Is Neither
Three decades of Alzheimer’s research have been organized around the conviction that the disease is, fundamentally, a problem with what is in the brain. Plaques, tangles, misfolded proteins, lost neurons. The most recent generation of disease-modifying therapies clears the targeted material with measurable success and produces, at best, marginal cognitive benefit. The field has been describing this gap as a problem of timing, dosage, or target refinement. This paper proposes that the gap is structural: the disease is not located where the field has been looking. Alzheimer’s, on the account developed here, is not primarily a failure of substrate. It is a failure of the dynamic operation that the substrate is meant to support — the operation by which a brain remains a coherent receiver of the structure presented to it. The paper installs this alternative frame, walks through the documented phenomena that current models cannot account for, and shows that each falls into place when the unit of analysis shifts from substrate to dynamics. What the disease destroys is not the receiver’s components. It is the receiver’s capacity to lock on.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Biologically Constrained Continuous-Time Framework for Long-Horizon Cognition Forecasting in Alzheimer’s Disease#475666
- Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer’s disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking#345382
- Overcoming the Blood-Brain Barrier for Targeted Drug Delivery in Neurological Diseases#77767
- Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872
- Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD#903489
Record · ID 166973
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive